We hypothesized that the activation of Sirt1/Nrf2/ARE signaling pathway induced by FMN could improve oxidative stress and that FMN probably prevents the progression of diabetic renal fibrosis and thereby represents a useful therapeutic option for patients with DN. The gene discussed is SIRT1; the disease is liver dysplastic nodule.